Cargando…

Unraveling the Immunopathogenesis and Genetic Variants in Vasculitis Toward Development of Personalized Medicine

Leukocytoclastic vasculitis (LCV) is a systemic autoimmune disease characterized by the inflammation of the vascular endothelium. Cutaneous small vessel vasculitis (CSVV) and anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) are two examples of LCV. Advancements in genomic te...

Descripción completa

Detalles Bibliográficos
Autores principales: Yap, Bryan Ju Min, Lai-Foenander, Ashley Sean, Goh, Bey Hing, Ong, Yong Sze, Duangjai, Acharaporn, Saokaew, Surasak, Chua, Caroline Lin Lin, Phisalprapa, Pochamana, Yap, Wei Hsum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491767/
https://www.ncbi.nlm.nih.gov/pubmed/34621800
http://dx.doi.org/10.3389/fcvm.2021.732369
_version_ 1784578793749348352
author Yap, Bryan Ju Min
Lai-Foenander, Ashley Sean
Goh, Bey Hing
Ong, Yong Sze
Duangjai, Acharaporn
Saokaew, Surasak
Chua, Caroline Lin Lin
Phisalprapa, Pochamana
Yap, Wei Hsum
author_facet Yap, Bryan Ju Min
Lai-Foenander, Ashley Sean
Goh, Bey Hing
Ong, Yong Sze
Duangjai, Acharaporn
Saokaew, Surasak
Chua, Caroline Lin Lin
Phisalprapa, Pochamana
Yap, Wei Hsum
author_sort Yap, Bryan Ju Min
collection PubMed
description Leukocytoclastic vasculitis (LCV) is a systemic autoimmune disease characterized by the inflammation of the vascular endothelium. Cutaneous small vessel vasculitis (CSVV) and anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) are two examples of LCV. Advancements in genomic technologies have identified risk haplotypes, genetic variants, susceptibility loci and pathways that are associated with vasculitis immunopathogenesis. The discovery of these genetic factors and their corresponding cellular signaling aberrations have enabled the development and use of novel therapeutic strategies for vasculitis. Personalized medicine aims to provide targeted therapies to individuals who show poor response to conventional interventions. For example, monoclonal antibody therapies have shown remarkable efficacy in achieving disease remission. Here, we discuss pathways involved in disease pathogenesis and the underlying genetic associations in different populations worldwide. Understanding the immunopathogenic pathways in vasculitis and identifying associated genetic variations will facilitate the development of novel and targeted personalized therapies for patients.
format Online
Article
Text
id pubmed-8491767
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84917672021-10-06 Unraveling the Immunopathogenesis and Genetic Variants in Vasculitis Toward Development of Personalized Medicine Yap, Bryan Ju Min Lai-Foenander, Ashley Sean Goh, Bey Hing Ong, Yong Sze Duangjai, Acharaporn Saokaew, Surasak Chua, Caroline Lin Lin Phisalprapa, Pochamana Yap, Wei Hsum Front Cardiovasc Med Cardiovascular Medicine Leukocytoclastic vasculitis (LCV) is a systemic autoimmune disease characterized by the inflammation of the vascular endothelium. Cutaneous small vessel vasculitis (CSVV) and anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) are two examples of LCV. Advancements in genomic technologies have identified risk haplotypes, genetic variants, susceptibility loci and pathways that are associated with vasculitis immunopathogenesis. The discovery of these genetic factors and their corresponding cellular signaling aberrations have enabled the development and use of novel therapeutic strategies for vasculitis. Personalized medicine aims to provide targeted therapies to individuals who show poor response to conventional interventions. For example, monoclonal antibody therapies have shown remarkable efficacy in achieving disease remission. Here, we discuss pathways involved in disease pathogenesis and the underlying genetic associations in different populations worldwide. Understanding the immunopathogenic pathways in vasculitis and identifying associated genetic variations will facilitate the development of novel and targeted personalized therapies for patients. Frontiers Media S.A. 2021-09-21 /pmc/articles/PMC8491767/ /pubmed/34621800 http://dx.doi.org/10.3389/fcvm.2021.732369 Text en Copyright © 2021 Yap, Lai-Foenander, Goh, Ong, Duangjai, Saokaew, Chua, Phisalprapa and Yap. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Yap, Bryan Ju Min
Lai-Foenander, Ashley Sean
Goh, Bey Hing
Ong, Yong Sze
Duangjai, Acharaporn
Saokaew, Surasak
Chua, Caroline Lin Lin
Phisalprapa, Pochamana
Yap, Wei Hsum
Unraveling the Immunopathogenesis and Genetic Variants in Vasculitis Toward Development of Personalized Medicine
title Unraveling the Immunopathogenesis and Genetic Variants in Vasculitis Toward Development of Personalized Medicine
title_full Unraveling the Immunopathogenesis and Genetic Variants in Vasculitis Toward Development of Personalized Medicine
title_fullStr Unraveling the Immunopathogenesis and Genetic Variants in Vasculitis Toward Development of Personalized Medicine
title_full_unstemmed Unraveling the Immunopathogenesis and Genetic Variants in Vasculitis Toward Development of Personalized Medicine
title_short Unraveling the Immunopathogenesis and Genetic Variants in Vasculitis Toward Development of Personalized Medicine
title_sort unraveling the immunopathogenesis and genetic variants in vasculitis toward development of personalized medicine
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491767/
https://www.ncbi.nlm.nih.gov/pubmed/34621800
http://dx.doi.org/10.3389/fcvm.2021.732369
work_keys_str_mv AT yapbryanjumin unravelingtheimmunopathogenesisandgeneticvariantsinvasculitistowarddevelopmentofpersonalizedmedicine
AT laifoenanderashleysean unravelingtheimmunopathogenesisandgeneticvariantsinvasculitistowarddevelopmentofpersonalizedmedicine
AT gohbeyhing unravelingtheimmunopathogenesisandgeneticvariantsinvasculitistowarddevelopmentofpersonalizedmedicine
AT ongyongsze unravelingtheimmunopathogenesisandgeneticvariantsinvasculitistowarddevelopmentofpersonalizedmedicine
AT duangjaiacharaporn unravelingtheimmunopathogenesisandgeneticvariantsinvasculitistowarddevelopmentofpersonalizedmedicine
AT saokaewsurasak unravelingtheimmunopathogenesisandgeneticvariantsinvasculitistowarddevelopmentofpersonalizedmedicine
AT chuacarolinelinlin unravelingtheimmunopathogenesisandgeneticvariantsinvasculitistowarddevelopmentofpersonalizedmedicine
AT phisalprapapochamana unravelingtheimmunopathogenesisandgeneticvariantsinvasculitistowarddevelopmentofpersonalizedmedicine
AT yapweihsum unravelingtheimmunopathogenesisandgeneticvariantsinvasculitistowarddevelopmentofpersonalizedmedicine